Clinical Trial Update: Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView. [Phase 4]

View source ↗

Summary

Phase 4 open-label study assessing the test-retest reproducibility of quantitative myocardial uptake measurements using AdreView (I-123 MIBG) in patients with h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Left Ventricular Dysfunction

Drugs mentioned

• ADREVIEW (IOBENGUANE I-123)

Snippet

Sponsor: GE Healthcare | Conditions: Heart Failure (HF), Ventricular Dysfunction, Left | Phase 4 | Status: COMPLETED | Results posted: 2015-01-26